Bill Sponsor
House Bill 841
117th Congress(2021-2022)
Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021
Introduced
Introduced
Introduced in House on Feb 4, 2021
Overview
Text
Introduced
Feb 4, 2021
Latest Action
Feb 5, 2021
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
841
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
Oregon
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
Colorado
Democrat
Colorado
Republican
Colorado
Democrat
District of Columbia
Republican
Florida
Republican
Illinois
Republican
Kentucky
Republican
Kentucky
Democrat
Kentucky
Democrat
Maryland
Democrat
Minnesota
Republican
Nebraska
Democrat
New Jersey
Republican
New York
Democrat
New York
Democrat
North Carolina
Republican
South Carolina
Democrat
Tennessee
Democrat
Tennessee
Republican
Washington
Democrat
Wisconsin
Democrat
Wisconsin
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021

This bill allows the use of hemp, cannabidiol (i.e., CBD) derived from hemp, or any other ingredient derived from hemp in a dietary supplement, provided that the supplement meets other applicable requirements. (Currently, the Food and Drug Administration's position is that CBD products may not be sold as dietary supplements.)

Text (1)
February 4, 2021
Actions (3)
02/05/2021
Referred to the Subcommittee on Health.
02/04/2021
Referred to the House Committee on Energy and Commerce.
02/04/2021
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:46:53 PM